14h
MyChesCo on MSNINOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory PapillomatosisINOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a ...
Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...
Researchers have discovered the mechanism that helps regulate the immune system’s response to helminth infection.
A virus originally found in animals, mpox -- which causes the disease of the same name -- is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic ...
22h
News Medical on MSNHow immune cells and neurons secretly shape brain health, behavior, and diseaseScientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...
Viral diseases remain a significant global health challenge, causing widespread morbidity and mortality. Advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results